[ Tips ] 一分鐘使用導覽
商品編號： W21038 出版日期： 2021/02/12 作者姓名： Agnihotri, Arpita;Bhattacharya, Saurabh 商品類別： Other 商品規格： 11p 再版日期： 地域： United States 產業： Fabrication and manufacturing;Pharmaceutical industry 個案年度： 2020 -
商品敘述：
In July 2020, Eastman Kodak Company (Kodak) received a US$765 million loan from the US federal government for drug component manufacturing. Kodak''s chief executive officer (CEO) was confident about the company''s ability to excel in the pharmaceutical industry. However, critics cited several concerns, such as workforce availability and Kodak''s lack of experience in the pharma business. The CEO believed that Kodak''s expertise in advanced chemicals and manufacturing could drive the firm''s success in the pharma business. Would Kodak be able to establish its mark in the US pharma industry? What challenges was Kodak likely to face? Arpita Agnihotri is affiliated with Pennsylvania State University - Harrisburg. Saurabh Bhattacharya is affiliated with Newcastle University.
涵蓋領域：
Company reputation;Core competencies;Diversification;Stock markets
相關資料：
Case Teaching Note, (W21039), 9p, by Arpita Agnihotri, Saurabh Bhattacharya
哪些人也有訂購？